Gurel, B
137  results:
Search for persons X
?
5

Olaparib and ceralasertib (AZD6738) in patients with triple..:

Ring, A ; Kilburn, L.S ; Pearson, A...
https://eprints.whiterose.ac.uk/207965/1/4751.pdf.  , 2023
 
?
6

A non-coding RNA balancing act: miR-346-induced DNA damage ..:

Fletcher, C. E ; Deng, L ; Orafidiya, F...
Fletcher , C E , Deng , L , Orafidiya , F , Yuan , W , Lorentzen , M P G S , Cyran , O W , Varela-Carver , A , Constantin , T A , Leach , D A , Dobbs , F M , Figueiredo , I , Gurel , B , Parkes , E , Bogdan , D , Pereira , R R , Zhao , S G , Neeb , A , Issa , F , Hester , J , Kudo , H , Liu , Y , Philippou , Y , Bristow , R , Knudsen , K , Bryant , R J , Feng , F Y , Reed , S H , Mills , I G , de Bono , J & Bevan , C L 2022 , ' A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer ' , Molecular Cancer , vol. 21 , 82 . https://doi.org/10.1186/s12943-022-01540-w.  , 2022
 
?
7

A non-coding RNA balancing act: miR-346-induced DNA damage ..:

Fletcher, C. E ; Deng, L ; Orafidiya, F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939142/.  , 2022
 
?
8

Phase 1, dose-escalation study of guadecitabine (SGI-110) i..:

Papadatos-Pastos, D ; Yuan, W ; Pal, A...
https://discovery.ucl.ac.uk/id/eprint/10152373/1/Parmar_Phase%201%20dose-escalation%20study%20of%20guadecitabine_VoR.pdf.  , 2022
 
?
11

HER3 Is an Actionable Target in Advanced Prostate Cancer:

Gil, V ; Miranda, S ; Riisnaes, R...
Cancer research, 2021, 81 (24), pp. 6207 - 6218.  , 2022
 
1-15